Head-to-head · Cost-Efficiency Index
Lttl vs Ascend Medical
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Lttl
Shoppers who want every commitment tier priced openly before intake, and who will read which rung the headline came from.
Visit LttlAscend Medical
Cost-first shoppers who want georgia or Texas residents who want to bill GLP-1 treatment through insurance rather than pay cash-only compounded pricing.
Visit Ascend MedicalThe verdict
Ascend Medical takes it, leading the Cost-Efficiency Index 57 to 55. Ascend Medical is an insurance-billed telehealth and in-person provider limited to Georgia and Texas residents. Lttl still earns a C — Shoppers who want every commitment tier priced openly before intake, and who will read which rung the headline came from.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Ascend Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Lttl | Ascend Medical |
|---|---|---|
| Cost-Efficiency Index | 55/100 | 57/100 |
| Semaglutide / mo | $199/mo (compounded) | Not disclosed |
| Tirzepatide / mo | $279/mo (compounded) | $240/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $3,348 | $2,880 |
| Coverage | Coverage not published | 2 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #295 | #299 |
Lttl
55/100Where the value is
- Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout, including the literal "$279/mo every month"
- Named medical advisory board (pharmacist, nurse practitioner, physical therapist) rather than zero disclosure
- Real LegitScript verification badge with a working certificate link
The tradeoffs
- Headline marketing price is a 12-month-prepay rate, not the true month-to-month cost — "Plans start at $129/mo" is $1,548 paid up front
- True cancel-anytime price is $199 semaglutide and $279 tirzepatide, 35–40% above the advertised "from" figures
Ascend Medical
57/100Where the value is
- Can bill through insurance, potentially lowering out-of-pocket cost versus cash-only compounded programs
- No-subscription, pay-per-refill model after the initial 8-week package
- Named metabolic-health chair referenced on the clinical team
The tradeoffs
- Only available to Georgia and Texas residents -- not a national service
- Unclear whether medication is compounded or brand-name; no compounding pharmacy named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.